In situ hybridisation has been used to detect mRNAs to the macrophage secretory products, lysozyme, interleukin 13 and tumour necrosis factor-a. Sections of paraformaldehyde fixed, frozen colonoscopic biopsies from patients with ulcerative colitis, Crohn's disease or normal controls were hybridised with specific radiolabelled probes and the signal detected by autoradiography. Lysozyme mRNA expression was more common in ulcerative colitis (22/27) and Crohn's disease (eight of eight) compared with controls (17/27). Positive celis were found mainly in the subepithelial region in normal colon, while in inflammatory bowel disease they also appeared in the deeper lamina propria. Immunocytochemistry in parallel sections showed that lysozyme mRNA was expressed only in macrophages or in metaplastic Paneth cells in longstanding inflammatory bowel disease. Tissue neutrophils did not express the lysozyme mRNA, though they have large stores of the protein. Tumour necrosis factor mRNA was detected in four of nine controls compared with 11/15 inflammatory bowel disease patients. For interleukin 113, three of eight controls were positive compared with 10/ 13 with ulcerative colitis. The tumour necrosis factor signal was located mainly in the deeper lamina propria whereas the interleukin 13 was seen in subepithelial macrophages.
A disturbance in immunoregulatory control has long been suspected to play a major role in the pathogenesis of inflammatory bowel disease. This belief is based on the observation of a variety of immune abnormalities, the response to immunosuppressive drugs and the pathology of the lesions. ' Macrophages are crucial cells in the immune and inflammatory events ongoing in the intestinal mucosa; being scattered just beneath the epithelium, they represent the first line of defence. They are phagocytic and are able to present antigen to sensitised T cells, they release a number of cytokines, inflammatory mediators, tissue damaging enzymes, and free oxygen radicals. 3 Previous studies have shown morphological and histochemical heterogeneity of human intestinal macrophages,4 with a distinct population being prominent in inflammatory bowel disease. Immunohistochemical studies 6 using monoclonal antibodies have added further information as there is a peculiar pattern of expression of surface antigenic determinants which is not seen in normal colon, infectious colitis, or graftversus-host disease. This pattern consists of the presence of cells staining with the 3G8 and RFD9 antibodies. Functional studies have provided evidence of macrophage activation: isolated mononuclear cells from the colonic mucosa of inflammatory bowel disease patients seem to have enhanced antigen presenting activity,' increased ability to undergo respiratory burst,' ability to stimulate immunoglobulin scretion,9 and to release the specific secretory products, lysozyme and interleukin 113. "' " Using the polymerase chain reaction, increased levels of mRNA for interleukin 1 have recently been shown in homogenates of mucosal biopsies from patients with inflammatory bowel disease, although the results for tumour necrosis factor mRNA are discrepant. 'B oth functional studies on isolated cells and conventional mRNA analysis on tissue homogenates, however, might generate artefactual changes that arise from tissue handling, cell disaggregation and separation, or in vitro culture. In situ hybridisation offers a unique means to overcome most of these problems because it is able to detect mRNA sequences within cells and therefore allows precise localisation within histological preparations. ' The aim of this study has been the use of in situ hybridisation to detect mRNAs for three specific macrophage products (lysozyme, interleukin 1 3, tumour necrosis factor a) in endoscopic biopsies of patients with ulcerative colitis or Crohn's disease.
Lysozyme is a major protein product of macrophages, and while it is produced constitutively in tissue culture, it is produced mainly by newly recruited or After hybridisation, coverslips were removed by incubating the slides in a solution of 50% formamide, 0-01% BSA, 0-01% Ficoll, 0-01% polyvinlypyrrolidone, 10 mM TRIS pH 7.4, 1 mM EDTA, 1 mM pyrophosphate, and 10 mM dithiothreitol at 50°C for one hour. The slides were washed in 0.5 M NaCl, 10 In normal colonic specimens lysozyme mRNA expression was found in cells lying beneath the surface epithelium in 17/27 cases (63%) (Fig 1) . In the remaining 10 control patients, there were occasional positive cells scattered throughout the lamina propria.
In ulcerative colitis lysozyme mRNA positive cells were more common than in controls as expression was found in 22 Little information is currently available on the role of interleukin 1 and tumour necrosis factor in inflammatory bowel disease."2"3 The present results show that there may be enhanced expression of tumour necrosis factor ct and interleukin 13 mRNAs in ulcerative colitis, and tumour necrosis factor a mRNA in Crohn's disease, compared with controls. Interestingly, the pattern of localisation of the two mRNAs is different, because the tumour necrosis factor signal is found mainly in the deeper lamina propria and the interleukin 1 signal mainly beneath the epithelium. This study cannot conclude with certainty the nature of the cells expressing mRNA for interleukin 1 or tumour necrosis factor, although the majority are probably macrophages. Thus, these data show functional heterogeneity within the intestinal macrophage population, with the appearance of at least two subsets of cells with a different secretory repertoire. Mahida et al,6 using conventional immunohistochemistry, identified unique subsets of macrophages in inflammatory bowel disease, staining with the monoclonal antibodies RFD9 and 3G8. 3G8 positive cells were distributed throughout the inflamed lamina propria but RFD9 positive cells appeared deeper in the lamina propria. Double labelling studies will be required to show definitely that tumour necrosis factor mRNA and RFD9 antigen are expressed by the same cells.
In conclusion, the use of specific molecular probes and in situ hybridisation allows a functional analysis of tissue macrophages. Phenotypic studies have previously shown intestinal macrophages to be a heterogeneous population and the present data show functional heterogeneity in inflamed tissue. These studies will be extended to investigate the expression of mRNA for other immunoregulatory cytokines.
